OTCMKTS:MXDHF - MDxHealth Stock Price, Price Target & More

$4.60 +0.40 (+9.52 %)
(As of 04/25/2018 04:00 PM ET)
Previous Close$4.20
Today's Range$4.60 - $4.60
52-Week Range$3.80 - $5.97
Volume27,500 shs
Average Volume8,360 shs
Market Capitalization$275.72 million
P/E RatioN/A
Dividend YieldN/A


MDxHealth logoMDxHealth SA, a molecular diagnostics company, develops and commercializes epigenetic and other molecular tests for cancer assessment and the personalized treatment of patients in Belgium and internationally. The company's tests are based on genetic, epigenetic (methylation) and other molecular technologies, and assist physicians with the diagnosis of urologic cancers, prognosis of recurrence risk, and prediction of response to a specific therapy. The company's products include ConfirmMDx, a solution for prostate cancer testing; and SelectMDx, a pre-biopsy diagnostic tool for prostate cancer. Its product pipeline includes tests for bladder, kidney, and other urologic cancers. The company was formerly known as OncoMethylome Sciences SA and changed its name to MDxHealth SA in October 2010. MDxHealth SA was founded in 2003 and is headquartered in Herstal, Belgium.

Receive MXDHF News and Ratings via Email

Sign-up to receive the latest news and ratings for MXDHF and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Private households


Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A


Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$40.51 million
Price / Sales6.81
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A


EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A


Outstanding Shares59,940,000

How to Become a New Pot Stock Millionaire

MDxHealth (OTCMKTS:MXDHF) Frequently Asked Questions

What is MDxHealth's stock symbol?

MDxHealth trades on the OTCMKTS under the ticker symbol "MXDHF."

When is MDxHealth's next earnings date?

MDxHealth is scheduled to release their next quarterly earnings announcement on Thursday, May, 24th 2018. View Earnings Estimates for MDxHealth.

Who are some of MDxHealth's key competitors?

Who are MDxHealth's key executives?

MDxHealth's management team includes the folowing people:
  • Dr. Jan Groen Ph.D., Chief Exec. Officer, Pres and Exec. Director (Age 58)
  • Mr. Jean-Marc Roelandt, Chief Financial Officer and Exec. VP (Age 53)
  • Dr. Wim Van Criekinge Prof., Ph.D., Chief Scientific Officer (Age 46)
  • Mr. Joseph Sollee J.D., LLM, Chief Compliance Officer, Exec. VP of Corp. Devel. and Gen. Counsel (Age 53)
  • Shalon Roth, Exec. VP of Corp. Communications & Public Affairs

Has MDxHealth been receiving favorable news coverage?

News coverage about MXDHF stock has been trending somewhat positive recently, Accern Sentiment Analysis reports. The research firm identifies positive and negative media coverage by monitoring more than twenty million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. MDxHealth earned a media sentiment score of 0.14 on Accern's scale. They also assigned news headlines about the company an impact score of 45.49 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the company's share price in the near future.

How do I buy shares of MDxHealth?

Shares of MXDHF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is MDxHealth's stock price today?

One share of MXDHF stock can currently be purchased for approximately $4.60.

How big of a company is MDxHealth?

MDxHealth has a market capitalization of $275.72 million and generates $40.51 million in revenue each year.

How can I contact MDxHealth?

MDxHealth's mailing address is CAP Business Center Rue d`Abhooz 31, Herstal C9, 4040. The company can be reached via phone at 324-364-2070 or via email at [email protected]

MarketBeat Community Rating for MDxHealth (MXDHF)

Community Ranking:  1.7 out of 5 (star)
Outperform Votes:  12 (Vote Outperform)
Underperform Votes:  23 (Vote Underperform)
Total Votes:  35
MarketBeat's community ratings are surveys of what our community members think about MDxHealth and other stocks. Vote "Outperform" if you believe MXDHF will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MXDHF will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

MDxHealth (OTCMKTS:MXDHF) Analyst Ratings History

DateBrokerageActionRatingPrice TargetDetails
(Data available from 4/25/2016 forward)



MDxHealth (OTCMKTS:MXDHF) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

MDxHealth (OTCMKTS MXDHF) Insider Trading and Institutional Ownership History

Insider Trading History for MDxHealth (OTCMKTS:MXDHF)

MDxHealth (OTCMKTS MXDHF) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
(Data available from 1/1/2013 forward)


MDxHealth (OTCMKTS MXDHF) News Headlines

MDxHealth (R): SelectMDx Included in Dutch DRG Reimbursement SystemMDxHealth (R): SelectMDx Included in Dutch DRG Reimbursement System
feeds.benzinga.com - April 20 at 2:09 AM
What You Must Know About MDxHealth SA’s (EBR:MDXH) Market RisksWhat You Must Know About MDxHealth SA’s (EBR:MDXH) Market Risks
finance.yahoo.com - April 18 at 8:36 AM
Breaking Down MDxHealth SA’s (EBR:MDXH) Ownership StructureBreaking Down MDxHealth SA’s (EBR:MDXH) Ownership Structure
finance.yahoo.com - April 10 at 3:23 PM
MDxHealth (MXDHF) Stock Rating Upgraded by Zacks Investment ResearchMDxHealth (MXDHF) Stock Rating Upgraded by Zacks Investment Research
www.americanbankingnews.com - April 8 at 6:28 PM
MDxHealth (MXDHF) Lifted to "Hold" at Zacks Investment ResearchMDxHealth (MXDHF) Lifted to "Hold" at Zacks Investment Research
www.americanbankingnews.com - March 29 at 6:22 PM
MDxHealth (R): Denominator PRMDxHealth (R): Denominator PR
feeds.benzinga.com - March 29 at 1:28 AM
MDxHealth (MXDHF) Downgraded to "Sell" at Zacks Investment ResearchMDxHealth (MXDHF) Downgraded to "Sell" at Zacks Investment Research
www.americanbankingnews.com - March 27 at 7:27 PM
Reviewing Fresenius (FSNUY) and MDxHealth (MXDHF)Reviewing Fresenius (FSNUY) and MDxHealth (MXDHF)
www.americanbankingnews.com - March 26 at 5:28 AM
MDxHealth SA (EBR:MDXH): Is Breakeven Near?MDxHealth SA (EBR:MDXH): Is Breakeven Near?
finance.yahoo.com - March 19 at 3:20 PM
MDxHealths prostate cancer liquid biopsy test included in European treatment guidelinesMDxHealth's prostate cancer liquid biopsy test included in European treatment guidelines
seekingalpha.com - March 19 at 7:49 AM
MDXHealth SA (MXDHF) Expected to Earn FY2018 Earnings of ($0.45) Per ShareMDXHealth SA (MXDHF) Expected to Earn FY2018 Earnings of ($0.45) Per Share
www.americanbankingnews.com - March 8 at 9:05 AM
MDXHealth SA (MXDHF) Forecasted to Post FY2019 Earnings of ($0.23) Per ShareMDXHealth SA (MXDHF) Forecasted to Post FY2019 Earnings of ($0.23) Per Share
www.americanbankingnews.com - March 7 at 2:45 PM

SEC Filings


This page is loading this company's SEC Filings. Please wait...

Social Media


Financials are not available for this stock.


MDxHealth (OTCMKTS MXDHF) Stock Chart for Wednesday, April, 25, 2018

Loading chart…

This page was last updated on 4/25/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.